Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01317381
Other study ID # Version 2.0. 08.12.2
Secondary ID
Status Recruiting
Phase Phase 4
First received August 23, 2010
Last updated March 15, 2011
Start date May 2010
Est. completion date May 2011

Study information

Verified date August 2010
Source University of Zurich
Contact 01 Studienregister MasterAdmins
Phone +41 (0)44 255 11 11
Is FDA regulated No
Health authority Switzerland: UZurich
Study type Observational

Clinical Trial Summary

ICG- Leberfunktionstest versus "neue" Biomarker als prognostischer Marker bei intensivmedizischen Patienten


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 2011
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion criteria: Gruppe 1:

- Intensiv-Patienten mit Verbrennungen > 10% der Körperoberfläche

- Alter > 18

Gruppe 2:

- Intensivpatienten nach grossen chirurgischen Eingriffen

- Alter > 18

Gruppe 3:

- Polytraumatisierte, intensivpflichtige Patienten

- Alter > 18

Exclusion criteria: • Alter < 18

- Schwangerschaft

- Einschluss in eine andere Studie

- Moribunde Patienten

- Patienten, die kein Deutsch verstehen

- Jodunverträglichkeit

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Observational
Blood draw

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of Zurich Intuitive Surgical

Country where clinical trial is conducted

Switzerland, 

See also
  Status Clinical Trial Phase
Recruiting NCT04045366 - Impact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients
Completed NCT01411553 - ECG Leadwires: Disposable Versus Cleaned, Reusable N/A
Completed NCT00288743 - Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study Phase 2
Recruiting NCT03529617 - Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates
Not yet recruiting NCT05564975 - Construction and Application of Pressure Injury Risk Prediction Model for Critically Ill Patients
Recruiting NCT06234787 - Continuous Subcutaneous Glucose Monitoring in Critical Patients
Completed NCT02198950 - Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
Completed NCT00470821 - Oral Melatonin in Critically Ill High-risk Patients Phase 4
Completed NCT00460252 - Tight Glycemic Control by eMPC Algorithm in Medical ICU Patients. N/A
Recruiting NCT06049979 - Correlation Between Intestinal Blood Flow and Intestinal Dysfunction in Critically Ill Patients
Active, not recruiting NCT04793568 - Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study Phase 2
Recruiting NCT05458687 - Traditional Chinese Medicine for Complications in Critically Ill Patients N/A
Completed NCT01963013 - Non-returning Catheter Valve for Reducing CAUTI N/A
Completed NCT01794468 - A New Monitor to Measure Dermal Blood Flow in Critically Ill Patients: a Preliminary Study N/A
Completed NCT03469882 - High Protein Intake and Early Exercise in Adult Intensive Care Patients N/A
Recruiting NCT04962204 - Virtual Visitation in Intensive Care Unit Study N/A
Completed NCT03205592 - Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients
Recruiting NCT01995565 - Regional Cerebral Hemodynamics Related to Global Hemodynamics N/A
Completed NCT00143494 - The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure N/A
Completed NCT00590928 - Gastric pH in Critically Ill Patients Phase 4